Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 02 - 19 crawled time : 12:03 save search
Broadwind Announces Fourth Quarter and Full-Year 2020 Results Conference Call Date
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
BWEN | $2.25 0.45% 0.44% 25K
|
Producer Manufacturing
|
| O: 5.1%
H: 5.4%
C: 0.77%
results
Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
FULC | $7.06 -1.26% -1.27% 530K
|
Health Technology
|
| O: 0.64%
H: 8.71%
C: 7.58%
conference therapeutics
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2020 Financial Results
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
CYCC | $1.86 -5.1% -5.38% 38K
|
Health Technology
|
| O: 3.21%
H: 4.18%
C: 1.67%
financial results results
Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
AVXL | $3.8 -6.63% -7.11% 1.7M
|
Health Technology
|
| O: 1.03%
H: 1.49%
C: -1.65%
life science trial anavex
Decibel Therapeutics to Present at the 44th Annual Association for Research in Otolaryngology (ARO) Conference
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
DBTX | $4.91 -0.81% -0.2% 0
|
Health Technology
|
| O: 0.05%
H: 3.22%
C: 2.14%
research
BioVie Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
BIVI | News | $0.488 3.52% 3.4% 1.4M
|
Health Technology
|
| O: 0.88%
H: 25.01%
C: 24.33%
Clene Nanomedicine to Present Updated Interim Data from Phase 2 Multiple Sclerosis Programs at ACTRIMS Forum 2021
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
CLNN S | $0.3275 -3.56% -3.69% 1.2M
|
|
| O: 0.36%
H: 3.15%
C: -2.44%
multiple sclerosis phase 2 sclerosis
Axsome Therapeutics to Present at Upcoming Investor Conferences
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
AXSM | $65.81 -5.6% -5.93% 830K
|
Health Technology
|
| O: 0.48%
H: 2.28%
C: 1.05%
conference presentation therapeutics
Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
PASG | $1.18 -7.09% -7.63% 120K
|
Health Technology
|
| O: -0.05%
H: 1.91%
C: -5.36%
Precision Announces 3-Year Pre-clinical Study Results Showing Long-term Durability and Safety of ARCUS In Vivo Gene Editing to Cut LDL Cholesterol Levels in Nonhuman Primates
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 1.15%
H: 9.25%
C: 6.89%
results arcus preclinical cholesterol pre-clinical
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.